PortfoliosLab logo

Aeglea BioTherapeutics, Inc. (AGLE)

Equity · Currency in USD · Last updated Nov 30, 2022

Company Info

ISINUS00773J1034
CUSIP00773J103
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$1.27
Year Range$0.38 - $6.17
EMA (50)$0.93
EMA (200)$1.78
Average Volume$1.64M
Market Capitalization$76.27M

AGLEShare Price Chart


Loading data...

AGLEPerformance

The chart shows the growth of $10,000 invested in Aeglea BioTherapeutics, Inc. in Apr 2016 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $1,249 for a total return of roughly -87.51%. All prices are adjusted for splits and dividends.


-80.00%-60.00%-40.00%-20.00%0.00%JulyAugustSeptemberOctoberNovember
-18.63%
-3.50%
AGLE (Aeglea BioTherapeutics, Inc.)
Benchmark (^GSPC)

AGLECompare to other instruments

Search for stocks, ETFs, and funds to compare with AGLE

AGLEReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M32.61%1.45%
6M-22.29%-4.82%
YTD-74.32%-16.96%
1Y-81.09%-13.86%
5Y-21.19%8.56%
10Y-26.90%10.51%

AGLEMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-9.47%-35.58%-16.97%-37.39%9.72%-68.04%-17.82%26.02%0.57%95.82%18.45%
2021-11.69%7.19%6.31%-1.77%-15.04%5.30%-11.93%18.27%9.66%-7.92%-14.75%-23.88%
2020-4.97%-5.92%-31.77%66.74%13.38%4.99%-25.95%6.20%-2.54%8.32%11.46%-8.06%
201922.03%-8.53%-3.71%-14.91%-8.91%9.78%30.80%-12.89%-1.47%-1.04%12.35%-10.64%
201819.78%11.88%36.83%-5.85%14.35%-0.94%-20.51%29.96%-12.44%-9.82%-2.43%-11.05%
2017-8.28%55.39%20.16%-4.03%-40.98%-8.77%-11.43%20.53%19.94%-11.15%-8.68%35.25%
2016-10.34%-14.38%-35.20%-1.23%17.50%13.65%-16.38%-3.54%-15.86%

AGLESharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Aeglea BioTherapeutics, Inc. Sharpe ratio is -0.53. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.80-0.60-0.40-0.200.00JulyAugustSeptemberOctoberNovember
-0.53
-0.63
AGLE (Aeglea BioTherapeutics, Inc.)
Benchmark (^GSPC)

AGLEDividend History


Aeglea BioTherapeutics, Inc. doesn't pay dividends

AGLEDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%2022FebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovember
-89.82%
-17.49%
AGLE (Aeglea BioTherapeutics, Inc.)
Benchmark (^GSPC)

AGLEWorst Drawdowns

The table below shows the maximum drawdowns of the Aeglea BioTherapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Aeglea BioTherapeutics, Inc. is 96.81%, recorded on Aug 2, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-96.81%Apr 11, 20161589Aug 2, 2022

AGLEVolatility Chart

Current Aeglea BioTherapeutics, Inc. volatility is 58.51%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%100.00%200.00%300.00%400.00%JulyAugustSeptemberOctoberNovember
58.51%
13.39%
AGLE (Aeglea BioTherapeutics, Inc.)
Benchmark (^GSPC)